Inventor · disambiguated record
Frank Süβmeier
Also filed as: SUE BGR MEIER FRANK · SUEBETAMEIER FRANK · SUESMEIER FRANK · SUEβMEIER FRANK
17 granted patents·6 pending applications·68 citations·filing 2003–2023
91Inventor score
Top patents by PatentIndex Score
23 records- 0188US8426602B2Heteroaryl-substituted dicyanopyridines and their useMEIBOM DANIEL·Filed 2009·Granted Apr 23, 2013·24 cites·5 claims
- 0287US9771352B2Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2015·Granted Sep 26, 2017·8 cites·15 claims
- 0387US7776922B2Substituted [(phenylethanoyl)amino]benzamidesBAYER SCHERING PHARMA AG·Filed 2005·Granted Aug 17, 2010·16 cites·7 claims
- 0483US8772498B2Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereofBAYER IP GMBH·Filed 2013·Granted Jul 8, 2014·5 cites·7 claims
- 0578US7662822B2Substituted azaquinazolines having an antiviral actionBAYER SCHERING PHARMA AG·Filed 2005·Granted Feb 16, 2010·3 cites·5 claims
- 0674US11912692B2Substituted S-alaninate derivativesBAYER AG·Filed 2023·Granted Feb 27, 2024·0 cites·17 claims
- 0774US8703934B2Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereofNELL PETER·Filed 2007·Granted Apr 22, 2014·2 cites·6 claims
- 0871US7960387B22-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegalovirusesBAYER SCHERING PHARMA AG·Filed 2004·Granted Jun 14, 2011·5 cites·4 claims
- 0969US7709491B2Substituted quinazolines as antiviral agents, especially against cytomegalovirusesBAYER SCHERING PHARMA AG·Filed 2003·Granted May 4, 2010·4 cites·15 claims
- 1061US9040691B2Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitorsKLAR JÜRGEN·Filed 2012·Granted May 26, 2015·1 cites·8 claims
- 1161US2013303559A1Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseasesBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 1258US10703742B2Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivativesBayer Pharma AG·Filed 2017·Granted Jul 7, 2020·0 cites·10 claims
- 1358US2014296515A1Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereofBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 1454US9205077B22-alkoxy-substituted dicyanopyridines and their useBAYER IP GMBH·Filed 2014·Granted Dec 8, 2015·0 cites·8 claims
- 1554US8791146B22-alkoxy-substituted dicyanopyridines and their useHübsch Walter·Filed 2009·Granted Jul 29, 2014·0 cites·9 claims
- 1650US8618119B2Fused cyanopyridines and the use thereofNELL PETER·Filed 2008·Granted Dec 31, 2013·0 cites·9 claims
- 1749US9394309B2Substituted phenylimidazopyrazoles and their useBAYER IP GMBH·Filed 2013·Granted Jul 19, 2016·0 cites·11 claims
- 1847US8609686B2Substituted azabicyclic compounds and the use thereofNELL PETER·Filed 2008·Granted Dec 17, 2013·0 cites·10 claims
- 1946US2017145029A1Cyclic thienouracil-carboxamides and use thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2042US2012029002A1Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseasesSTRAUB ALEXANDER·Filed 2010·Application pending·0 cites
- 2141US2017313665A1Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2241US2016130230A1Substituted dicyanopyridines and use thereofVAKALOPOULOS ALEXANDROS·Filed 2015·Application pending·0 cites
- 2336US10428083B2Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptorBayer Pharma AG·Filed 2016·Granted Oct 1, 2019·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →